

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.61175349 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.58391403 |
| 3 | response to peptidoglycan (GO:0032494) | 4.75127886 |
| 4 | NIK/NF-kappaB signaling (GO:0038061) | 4.63021780 |
| 5 | positive regulation of interferon-alpha production (GO:0032727) | 4.55843105 |
| 6 | regulation of interferon-alpha production (GO:0032647) | 4.38638337 |
| 7 | negative regulation of interleukin-12 production (GO:0032695) | 4.32730479 |
| 8 | natural killer cell mediated cytotoxicity (GO:0042267) | 4.31641183 |
| 9 | natural killer cell mediated immunity (GO:0002228) | 4.31641183 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.28364280 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 4.23115217 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 4.23115217 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.23115217 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.23115217 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.23115217 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 4.23115217 |
| 17 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.15182863 |
| 18 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.14607922 |
| 19 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.13350612 |
| 20 | granulocyte activation (GO:0036230) | 4.12734252 |
| 21 | neutrophil activation (GO:0042119) | 4.05146379 |
| 22 | positive regulation of heat generation (GO:0031652) | 3.95305828 |
| 23 | regulation of activation of Janus kinase activity (GO:0010533) | 3.93962971 |
| 24 | regulation of T cell tolerance induction (GO:0002664) | 3.92558291 |
| 25 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.92027953 |
| 26 | regulation of RIG-I signaling pathway (GO:0039535) | 3.89946442 |
| 27 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.88505805 |
| 28 | respiratory burst (GO:0045730) | 3.86657708 |
| 29 | positive regulation of interleukin-12 production (GO:0032735) | 3.85582355 |
| 30 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.83725073 |
| 31 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.81247284 |
| 32 | regulation of fever generation (GO:0031620) | 3.80608541 |
| 33 | response to muramyl dipeptide (GO:0032495) | 3.79695096 |
| 34 | cellular response to type I interferon (GO:0071357) | 3.79136321 |
| 35 | type I interferon signaling pathway (GO:0060337) | 3.79136321 |
| 36 | activated T cell proliferation (GO:0050798) | 3.76174144 |
| 37 | response to type I interferon (GO:0034340) | 3.76007219 |
| 38 | myeloid dendritic cell differentiation (GO:0043011) | 3.75591137 |
| 39 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.68718406 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 3.66803209 |
| 41 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.65593913 |
| 42 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.65430923 |
| 43 | cellular response to interferon-beta (GO:0035458) | 3.64525003 |
| 44 | response to interleukin-15 (GO:0070672) | 3.61558782 |
| 45 | regulation of chronic inflammatory response (GO:0002676) | 3.60205323 |
| 46 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.59612825 |
| 47 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.59543775 |
| 48 | positive regulation of antigen processing and presentation (GO:0002579) | 3.57079713 |
| 49 | positive regulation of tolerance induction (GO:0002645) | 3.56622188 |
| 50 | cellular response to zinc ion (GO:0071294) | 3.54169465 |
| 51 | negative regulation of cell killing (GO:0031342) | 3.53761525 |
| 52 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.53761525 |
| 53 | cellular response to interleukin-15 (GO:0071350) | 3.53591054 |
| 54 | regulation of tolerance induction (GO:0002643) | 3.53290382 |
| 55 | regulation of gamma-delta T cell activation (GO:0046643) | 3.52275973 |
| 56 | myeloid dendritic cell activation (GO:0001773) | 3.51960159 |
| 57 | negative T cell selection (GO:0043383) | 3.50792093 |
| 58 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.49975015 |
| 59 | detection of molecule of bacterial origin (GO:0032490) | 3.47699153 |
| 60 | leukocyte aggregation (GO:0070486) | 3.45562968 |
| 61 | cellular response to exogenous dsRNA (GO:0071360) | 3.45084948 |
| 62 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.42975480 |
| 63 | defense response to protozoan (GO:0042832) | 3.42189831 |
| 64 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.40882755 |
| 65 | macrophage activation involved in immune response (GO:0002281) | 3.40471611 |
| 66 | regulation of regulatory T cell differentiation (GO:0045589) | 3.39156199 |
| 67 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.38758375 |
| 68 | leukocyte mediated cytotoxicity (GO:0001909) | 3.38671976 |
| 69 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.36496720 |
| 70 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.35308909 |
| 71 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.34907029 |
| 72 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.34278478 |
| 73 | cytidine deamination (GO:0009972) | 3.33750941 |
| 74 | cytidine metabolic process (GO:0046087) | 3.33750941 |
| 75 | cytidine catabolic process (GO:0006216) | 3.33750941 |
| 76 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.32596200 |
| 77 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.32596200 |
| 78 | positive regulation of interferon-beta production (GO:0032728) | 3.30961444 |
| 79 | positive regulation of interleukin-2 production (GO:0032743) | 3.30585011 |
| 80 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.28747276 |
| 81 | reactive oxygen species biosynthetic process (GO:1903409) | 3.28050634 |
| 82 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.27212812 |
| 83 | T cell migration (GO:0072678) | 3.27206284 |
| 84 | superoxide anion generation (GO:0042554) | 3.25924974 |
| 85 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.25365902 |
| 86 | T-helper 1 type immune response (GO:0042088) | 3.24808387 |
| 87 | positive regulation of type 2 immune response (GO:0002830) | 3.24037387 |
| 88 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.23960788 |
| 89 | regulation of chemokine biosynthetic process (GO:0045073) | 3.22946964 |
| 90 | positive regulation of interleukin-17 production (GO:0032740) | 3.21160377 |
| 91 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.21066662 |
| 92 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.21066662 |
| 93 | negative thymic T cell selection (GO:0045060) | 3.19506740 |
| 94 | necroptotic process (GO:0070266) | 3.18442487 |
| 95 | negative regulation of viral genome replication (GO:0045071) | 3.18372869 |
| 96 | myeloid cell activation involved in immune response (GO:0002275) | 3.17840492 |
| 97 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.17600781 |
| 98 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.17444908 |
| 99 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.16419813 |
| 100 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.16211597 |
| 101 | eosinophil chemotaxis (GO:0048245) | 3.14815466 |
| 102 | negative regulation of interleukin-17 production (GO:0032700) | 3.14619652 |
| 103 | dendritic cell differentiation (GO:0097028) | 3.14453233 |
| 104 | regulation of antigen processing and presentation (GO:0002577) | 3.13720395 |
| 105 | regulation of interleukin-12 production (GO:0032655) | 3.13665678 |
| 106 | negative regulation of T cell mediated immunity (GO:0002710) | 3.13154765 |
| 107 | response to interferon-beta (GO:0035456) | 3.13122101 |
| 108 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.11125526 |
| 109 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.09622198 |
| 110 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.08098388 |
| 111 | cytokine secretion (GO:0050663) | 3.08056755 |
| 112 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.07986461 |
| 113 | positive regulation of defense response to virus by host (GO:0002230) | 3.07886499 |
| 114 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.07373138 |
| 115 | regulation of interleukin-17 production (GO:0032660) | 3.07058537 |
| 116 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.04801160 |
| 117 | monocyte chemotaxis (GO:0002548) | 3.03814952 |
| 118 | positive regulation of B cell differentiation (GO:0045579) | 3.00586736 |
| 119 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.98109042 |
| 120 | cellular extravasation (GO:0045123) | 2.97765107 |
| 121 | response to protozoan (GO:0001562) | 2.97382112 |
| 122 | response to interferon-alpha (GO:0035455) | 2.97227923 |
| 123 | regulation of hypersensitivity (GO:0002883) | 2.97092320 |
| 124 | positive regulation of lymphocyte migration (GO:2000403) | 2.96925081 |
| 125 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.95024381 |
| 126 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.94919553 |
| 127 | response to host immune response (GO:0052572) | 2.94919553 |
| 128 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.94830232 |
| 129 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.94160921 |
| 130 | regulation of T-helper cell differentiation (GO:0045622) | 2.93941200 |
| 131 | lymphocyte chemotaxis (GO:0048247) | 2.92958648 |
| 132 | positive regulation of interleukin-10 production (GO:0032733) | 2.92446781 |
| 133 | regulation of T-helper 1 type immune response (GO:0002825) | 2.91129632 |
| 134 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.89127269 |
| 135 | positive regulation of T cell cytokine production (GO:0002726) | 2.88807971 |
| 136 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.87982861 |
| 137 | regulation of heat generation (GO:0031650) | 2.87944861 |
| 138 | B cell mediated immunity (GO:0019724) | 2.87825526 |
| 139 | regulation of B cell differentiation (GO:0045577) | 2.87540652 |
| 140 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.87413886 |
| 141 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.86532928 |
| 142 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.85128853 |
| 143 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.85128853 |
| 144 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.83742587 |
| 145 | DNA deamination (GO:0045006) | 2.82863576 |
| 146 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.82857731 |
| 147 | detection of biotic stimulus (GO:0009595) | 2.81915067 |
| 148 | programmed necrotic cell death (GO:0097300) | 2.81692944 |
| 149 | microglial cell activation (GO:0001774) | 2.81588881 |
| 150 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.81437410 |
| 151 | positive regulation of T cell chemotaxis (GO:0010820) | 2.80713065 |
| 152 | regulation of T cell chemotaxis (GO:0010819) | 2.80713065 |
| 153 | positive regulation of humoral immune response (GO:0002922) | 2.78292663 |
| 154 | dendritic cell migration (GO:0036336) | 2.73341362 |
| 155 | interferon-gamma production (GO:0032609) | 2.72935081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 7.57739324 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.64849549 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.63440887 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.13626146 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 5.03411566 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.64392043 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.15883017 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.68182541 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.60609347 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.43956689 |
| 11 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.27158928 |
| 12 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.18112761 |
| 13 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.17711761 |
| 14 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.04894514 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.95989432 |
| 16 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.94179719 |
| 17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.90688798 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.59743383 |
| 19 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.21448442 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.02258817 |
| 21 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.00482762 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 2.00386277 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.96666400 |
| 24 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.91486636 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.91081740 |
| 26 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.84980700 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83421859 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.82504817 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.79648282 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.77862327 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.71862475 |
| 32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.71060375 |
| 33 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.70453390 |
| 34 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.65354330 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.63951235 |
| 36 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.61663635 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.60776575 |
| 38 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.59572612 |
| 39 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52566543 |
| 40 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.51241472 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.49728075 |
| 42 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48328419 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.45992365 |
| 44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.45867587 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.44294225 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40335702 |
| 47 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.38713596 |
| 48 | MAF_26560356_Chip-Seq_TH1_Human | 1.38123147 |
| 49 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.37547868 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37502058 |
| 51 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.35344312 |
| 52 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.34561007 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.33435156 |
| 54 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32780921 |
| 55 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.31655370 |
| 56 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.30817888 |
| 57 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30450535 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.29547958 |
| 59 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28284972 |
| 60 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26769806 |
| 61 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.22928157 |
| 62 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.18677056 |
| 63 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.16357016 |
| 64 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15966431 |
| 65 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.15501476 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14757475 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13623894 |
| 68 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.13518190 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10491514 |
| 70 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09313378 |
| 71 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07646059 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06833548 |
| 73 | * IGF1R_20145208_ChIP-Seq_DFB_Human | 1.05198140 |
| 74 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.04751301 |
| 75 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.04400981 |
| 76 | * VDR_22108803_ChIP-Seq_LS180_Human | 1.04261680 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.03956105 |
| 78 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03772659 |
| 79 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01113302 |
| 80 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.99280078 |
| 81 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98879874 |
| 82 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.98057857 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.98057857 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97973043 |
| 85 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97859614 |
| 86 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96550099 |
| 87 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.96498901 |
| 88 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94954958 |
| 89 | P300_19829295_ChIP-Seq_ESCs_Human | 0.94293674 |
| 90 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.93313750 |
| 91 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.92345116 |
| 92 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.91983679 |
| 93 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.91837588 |
| 94 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91338706 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90650901 |
| 96 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89585963 |
| 97 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.89388308 |
| 98 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.89181284 |
| 99 | GATA3_26560356_Chip-Seq_TH1_Human | 0.87874585 |
| 100 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.87550882 |
| 101 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.87469321 |
| 102 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.85446348 |
| 103 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.85050687 |
| 104 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84928208 |
| 105 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.84868820 |
| 106 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.84713600 |
| 107 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84699281 |
| 108 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84535883 |
| 109 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.84257260 |
| 110 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.83919089 |
| 111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83741030 |
| 112 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83670540 |
| 113 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83200840 |
| 114 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.83194619 |
| 115 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.83101744 |
| 116 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.82895726 |
| 117 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81776314 |
| 118 | UTX_26944678_Chip-Seq_JUKART_Human | 0.81622254 |
| 119 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.77976225 |
| 120 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.76279095 |
| 121 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.75439855 |
| 122 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.75439855 |
| 123 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.73288973 |
| 124 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73243660 |
| 125 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.73105077 |
| 126 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72143422 |
| 127 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.71981503 |
| 128 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.70615536 |
| 129 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.68724321 |
| 130 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.67942360 |
| 131 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67641517 |
| 132 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.67457840 |
| 133 | MAF_26560356_Chip-Seq_TH2_Human | 0.67365947 |
| 134 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.67127339 |
| 135 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.67097432 |
| 136 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.66379424 |
| 137 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64622228 |
| 138 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.63492997 |
| 139 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.62685483 |
| 140 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.62190034 |
| 141 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.61701110 |
| 142 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.61392556 |
| 143 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.60643939 |
| 144 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.59998543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.02851734 |
| 2 | MP0009785_altered_susceptibility_to | 4.21071200 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.86339807 |
| 4 | MP0000685_abnormal_immune_system | 3.53594880 |
| 5 | MP0003436_decreased_susceptibility_to | 3.52666074 |
| 6 | * MP0005000_abnormal_immune_tolerance | 3.31937537 |
| 7 | MP0001790_abnormal_immune_system | 3.11395783 |
| 8 | MP0005387_immune_system_phenotype | 3.11395783 |
| 9 | MP0005671_abnormal_response_to | 3.09097852 |
| 10 | MP0005025_abnormal_response_to | 3.06333714 |
| 11 | * MP0002419_abnormal_innate_immunity | 3.05907565 |
| 12 | MP0003724_increased_susceptibility_to | 3.03314801 |
| 13 | MP0006082_CNS_inflammation | 2.95683714 |
| 14 | * MP0001800_abnormal_humoral_immune | 2.80218936 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.77729293 |
| 16 | * MP0002723_abnormal_immune_serum | 2.67582738 |
| 17 | MP0004510_myositis | 2.59615685 |
| 18 | MP0003303_peritoneal_inflammation | 2.44537958 |
| 19 | * MP0001819_abnormal_immune_cell | 2.41445465 |
| 20 | MP0002006_tumorigenesis | 2.39387985 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 2.38091271 |
| 22 | MP0001853_heart_inflammation | 2.23690211 |
| 23 | MP0002254_reproductive_system_inflammat | 2.10665601 |
| 24 | MP0009764_decreased_sensitivity_to | 1.97220095 |
| 25 | MP0004947_skin_inflammation | 1.95414607 |
| 26 | MP0005310_abnormal_salivary_gland | 1.95250340 |
| 27 | MP0001533_abnormal_skeleton_physiology | 1.92320025 |
| 28 | MP0002138_abnormal_hepatobiliary_system | 1.90842982 |
| 29 | * MP0001845_abnormal_inflammatory_respons | 1.90104993 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.87407754 |
| 31 | * MP0002405_respiratory_system_inflammati | 1.86277872 |
| 32 | MP0002166_altered_tumor_susceptibility | 1.83227935 |
| 33 | * MP0000716_abnormal_immune_system | 1.75230655 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.72678674 |
| 35 | MP0003448_altered_tumor_morphology | 1.72005902 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.71774794 |
| 37 | * MP0002398_abnormal_bone_marrow | 1.68721501 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.66437974 |
| 39 | MP0008469_abnormal_protein_level | 1.66202431 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.66074259 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.54231567 |
| 42 | MP0000858_altered_metastatic_potential | 1.46999380 |
| 43 | MP0002277_abnormal_respiratory_mucosa | 1.46044698 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.38392245 |
| 45 | * MP0002429_abnormal_blood_cell | 1.37634015 |
| 46 | MP0001348_abnormal_lacrimal_gland | 1.32879785 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.32497095 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.32497095 |
| 49 | MP0005451_abnormal_body_composition | 1.31613596 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.31338220 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.27932054 |
| 52 | MP0003075_altered_response_to | 1.27290515 |
| 53 | * MP0000689_abnormal_spleen_morphology | 1.27129195 |
| 54 | MP0000343_altered_response_to | 1.26047604 |
| 55 | MP0003195_calcinosis | 1.26018833 |
| 56 | MP0001873_stomach_inflammation | 1.25243511 |
| 57 | * MP0002722_abnormal_immune_system | 1.22500972 |
| 58 | MP0005084_abnormal_gallbladder_morpholo | 1.22000709 |
| 59 | MP0004782_abnormal_surfactant_physiolog | 1.21135782 |
| 60 | MP0003186_abnormal_redox_activity | 1.14478414 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.12501661 |
| 62 | MP0009278_abnormal_bone_marrow | 1.12485392 |
| 63 | MP0002163_abnormal_gland_morphology | 1.12127298 |
| 64 | MP0003045_fibrosis | 1.09991863 |
| 65 | MP0004883_abnormal_blood_vessel | 1.05019725 |
| 66 | MP0002332_abnormal_exercise_endurance | 1.03918740 |
| 67 | MP0003950_abnormal_plasma_membrane | 1.01354733 |
| 68 | MP0003252_abnormal_bile_duct | 0.99470107 |
| 69 | MP0000604_amyloidosis | 0.98455686 |
| 70 | MP0009763_increased_sensitivity_to | 0.97876112 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 0.95294083 |
| 72 | MP0002933_joint_inflammation | 0.94797535 |
| 73 | MP0003011_delayed_dark_adaptation | 0.94754796 |
| 74 | MP0005164_abnormal_response_to | 0.93074144 |
| 75 | MP0005379_endocrine/exocrine_gland_phen | 0.92247537 |
| 76 | MP0005166_decreased_susceptibility_to | 0.91004593 |
| 77 | MP0003183_abnormal_peptide_metabolism | 0.90677445 |
| 78 | MP0005390_skeleton_phenotype | 0.89701228 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 0.87027628 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.84698624 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 0.83827433 |
| 82 | MP0005174_abnormal_tail_pigmentation | 0.83226503 |
| 83 | MP0002396_abnormal_hematopoietic_system | 0.81860908 |
| 84 | MP0001851_eye_inflammation | 0.78571154 |
| 85 | MP0003828_pulmonary_edema | 0.78105582 |
| 86 | MP0001346_abnormal_lacrimal_gland | 0.76388898 |
| 87 | MP0000703_abnormal_thymus_morphology | 0.75764049 |
| 88 | MP0005076_abnormal_cell_differentiation | 0.75210007 |
| 89 | MP0010352_gastrointestinal_tract_polyps | 0.75085002 |
| 90 | MP0002877_abnormal_melanocyte_morpholog | 0.74820570 |
| 91 | MP0008057_abnormal_DNA_replication | 0.74476385 |
| 92 | MP0001881_abnormal_mammary_gland | 0.73040802 |
| 93 | MP0003690_abnormal_glial_cell | 0.72287997 |
| 94 | MP0005645_abnormal_hypothalamus_physiol | 0.71445552 |
| 95 | MP0003091_abnormal_cell_migration | 0.71329475 |
| 96 | MP0000249_abnormal_blood_vessel | 0.71138735 |
| 97 | MP0006054_spinal_hemorrhage | 0.69755300 |
| 98 | MP0000371_diluted_coat_color | 0.69491225 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 0.67713146 |
| 100 | MP0004381_abnormal_hair_follicle | 0.67435093 |
| 101 | MP0003221_abnormal_cardiomyocyte_apopto | 0.66221254 |
| 102 | MP0010307_abnormal_tumor_latency | 0.65968305 |
| 103 | MP0003866_abnormal_defecation | 0.64236960 |
| 104 | MP0003566_abnormal_cell_adhesion | 0.62804207 |
| 105 | MP0000015_abnormal_ear_pigmentation | 0.61870020 |
| 106 | MP0002132_abnormal_respiratory_system | 0.61599356 |
| 107 | MP0000490_abnormal_crypts_of | 0.61422147 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.60935391 |
| 109 | MP0002139_abnormal_hepatobiliary_system | 0.60020765 |
| 110 | MP0002693_abnormal_pancreas_physiology | 0.59740158 |
| 111 | MP0005376_homeostasis/metabolism_phenot | 0.59227449 |
| 112 | MP0002009_preneoplasia | 0.58470455 |
| 113 | MP0003795_abnormal_bone_structure | 0.58038946 |
| 114 | MP0000372_irregular_coat_pigmentation | 0.57628733 |
| 115 | MP0001764_abnormal_homeostasis | 0.56738452 |
| 116 | MP0008873_increased_physiological_sensi | 0.56673149 |
| 117 | MP0001663_abnormal_digestive_system | 0.55914762 |
| 118 | MP0000427_abnormal_hair_cycle | 0.55594159 |
| 119 | MP0004808_abnormal_hematopoietic_stem | 0.55580565 |
| 120 | MP0000627_abnormal_mammary_gland | 0.54634327 |
| 121 | MP0005075_abnormal_melanosome_morpholog | 0.53791361 |
| 122 | MP0008260_abnormal_autophagy | 0.53669360 |
| 123 | * MP0000609_abnormal_liver_physiology | 0.53044526 |
| 124 | * MP0002136_abnormal_kidney_physiology | 0.52597266 |
| 125 | MP0002876_abnormal_thyroid_physiology | 0.49446055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.06424055 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.02014896 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.70182917 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.35343961 |
| 5 | Mediastinal lymphadenopathy (HP:0100721) | 5.17820004 |
| 6 | Optic neuritis (HP:0100653) | 5.10090042 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 5.10090042 |
| 8 | Orchitis (HP:0100796) | 4.95271145 |
| 9 | Myositis (HP:0100614) | 4.93988110 |
| 10 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.93511486 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 4.44949790 |
| 12 | Recurrent skin infections (HP:0001581) | 4.41804086 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.37798907 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.37669597 |
| 15 | Vasculitis (HP:0002633) | 4.23794592 |
| 16 | Increased IgM level (HP:0003496) | 4.17486916 |
| 17 | Stomatitis (HP:0010280) | 3.92729803 |
| 18 | Gingivitis (HP:0000230) | 3.91918091 |
| 19 | Recurrent viral infections (HP:0004429) | 3.79617446 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.63072224 |
| 21 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.63072224 |
| 22 | Obstructive lung disease (HP:0006536) | 3.57016959 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 3.57016959 |
| 24 | Pulmonary infiltrates (HP:0002113) | 3.41973840 |
| 25 | Periodontitis (HP:0000704) | 3.29327417 |
| 26 | Basal ganglia calcification (HP:0002135) | 3.26249721 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 3.25704172 |
| 28 | Recurrent pneumonia (HP:0006532) | 3.17226114 |
| 29 | Meningitis (HP:0001287) | 3.10219846 |
| 30 | Keratoconjunctivitis sicca (HP:0001097) | 3.09182567 |
| 31 | Hypergammaglobulinemia (HP:0010702) | 3.04907969 |
| 32 | Cellulitis (HP:0100658) | 3.02938899 |
| 33 | Keratoconjunctivitis (HP:0001096) | 3.01464030 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 2.96535271 |
| 35 | Abnormality of T cell number (HP:0011839) | 2.96369499 |
| 36 | Arterial thrombosis (HP:0004420) | 2.95886346 |
| 37 | Pustule (HP:0200039) | 2.92506556 |
| 38 | Tetraparesis (HP:0002273) | 2.86167364 |
| 39 | Hemoptysis (HP:0002105) | 2.84006401 |
| 40 | Chronic otitis media (HP:0000389) | 2.83587055 |
| 41 | Leukocytosis (HP:0001974) | 2.78439684 |
| 42 | Recurrent lower respiratory tract infections (HP:0002783) | 2.77421887 |
| 43 | Urticaria (HP:0001025) | 2.76152518 |
| 44 | Eosinophilia (HP:0001880) | 2.75964534 |
| 45 | Interstitial pulmonary disease (HP:0006530) | 2.75409172 |
| 46 | Prostate neoplasm (HP:0100787) | 2.75247509 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 2.73217232 |
| 48 | Autoimmune hemolytic anemia (HP:0001890) | 2.72958108 |
| 49 | Thick nail (HP:0001805) | 2.70463160 |
| 50 | Osteomyelitis (HP:0002754) | 2.62935568 |
| 51 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.62295640 |
| 52 | Agammaglobulinemia (HP:0004432) | 2.53816578 |
| 53 | Keratitis (HP:0000491) | 2.50257750 |
| 54 | T lymphocytopenia (HP:0005403) | 2.50005573 |
| 55 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.49530667 |
| 56 | Abnormality of glycolipid metabolism (HP:0010969) | 2.47478824 |
| 57 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.47478824 |
| 58 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.47478824 |
| 59 | Fatigue (HP:0012378) | 2.45064031 |
| 60 | Gangrene (HP:0100758) | 2.44276219 |
| 61 | Polyneuropathy (HP:0001271) | 2.43476406 |
| 62 | Chest pain (HP:0100749) | 2.43438886 |
| 63 | Pulmonary embolism (HP:0002204) | 2.39561899 |
| 64 | Gastrointestinal stroma tumor (HP:0100723) | 2.37874827 |
| 65 | Thrombocytosis (HP:0001894) | 2.37493729 |
| 66 | Premature loss of primary teeth (HP:0006323) | 2.35927953 |
| 67 | IgA deficiency (HP:0002720) | 2.35660633 |
| 68 | Increased cerebral lipofuscin (HP:0011813) | 2.34785495 |
| 69 | Abnormality of eosinophils (HP:0001879) | 2.33284721 |
| 70 | Joint swelling (HP:0001386) | 2.33165809 |
| 71 | Myocardial infarction (HP:0001658) | 2.32727317 |
| 72 | Abnormality of T cells (HP:0002843) | 2.31567730 |
| 73 | Abnormality of B cell number (HP:0010975) | 2.29293123 |
| 74 | Severe combined immunodeficiency (HP:0004430) | 2.29123997 |
| 75 | Gingival bleeding (HP:0000225) | 2.29088428 |
| 76 | Vertebral compression fractures (HP:0002953) | 2.28352954 |
| 77 | Axonal loss (HP:0003447) | 2.28133751 |
| 78 | Encephalitis (HP:0002383) | 2.27905350 |
| 79 | Petechiae (HP:0000967) | 2.27115716 |
| 80 | Recurrent bronchitis (HP:0002837) | 2.26512328 |
| 81 | Granulocytopenia (HP:0001913) | 2.26039334 |
| 82 | Chronic diarrhea (HP:0002028) | 2.25202728 |
| 83 | Abnormality of the prostate (HP:0008775) | 2.24531378 |
| 84 | Abnormality of the pericardium (HP:0001697) | 2.22905383 |
| 85 | Osteolytic defects of the hand bones (HP:0009699) | 2.22463551 |
| 86 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.22463551 |
| 87 | Abnormality of T cell physiology (HP:0011840) | 2.21902971 |
| 88 | Colitis (HP:0002583) | 2.21792012 |
| 89 | Anorexia (HP:0002039) | 2.21505896 |
| 90 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.21292379 |
| 91 | Arthralgia (HP:0002829) | 2.19158425 |
| 92 | IgG deficiency (HP:0004315) | 2.13533994 |
| 93 | Spontaneous hematomas (HP:0007420) | 2.13457203 |
| 94 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.13251907 |
| 95 | Porencephaly (HP:0002132) | 2.13151826 |
| 96 | Disinhibition (HP:0000734) | 2.12034959 |
| 97 | Hypoproteinemia (HP:0003075) | 2.11640905 |
| 98 | Hydroxyprolinuria (HP:0003080) | 2.09575222 |
| 99 | Abnormality of proline metabolism (HP:0010907) | 2.09575222 |
| 100 | Skin ulcer (HP:0200042) | 2.07162513 |
| 101 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.06956818 |
| 102 | Alveolar cell carcinoma (HP:0006519) | 2.04799489 |
| 103 | Lymphopenia (HP:0001888) | 2.03659161 |
| 104 | Inflammation of the large intestine (HP:0002037) | 2.01832022 |
| 105 | Increased IgE level (HP:0003212) | 1.99470481 |
| 106 | Sepsis (HP:0100806) | 1.98789124 |
| 107 | Glomerulopathy (HP:0100820) | 1.98112567 |
| 108 | Poor head control (HP:0002421) | 1.97388651 |
| 109 | Panhypogammaglobulinemia (HP:0003139) | 1.96246962 |
| 110 | Abnormality of the pleura (HP:0002103) | 1.96045829 |
| 111 | Thyroiditis (HP:0100646) | 1.95327232 |
| 112 | Acute hepatic failure (HP:0006554) | 1.94674503 |
| 113 | 3-Methylglutaconic aciduria (HP:0003535) | 1.94423231 |
| 114 | Pulmonary fibrosis (HP:0002206) | 1.92547232 |
| 115 | Bone pain (HP:0002653) | 1.88808667 |
| 116 | Vertigo (HP:0002321) | 1.87895908 |
| 117 | Loss of speech (HP:0002371) | 1.86548358 |
| 118 | B lymphocytopenia (HP:0010976) | 1.85583298 |
| 119 | Hepatosplenomegaly (HP:0001433) | 1.85372468 |
| 120 | Gastrointestinal inflammation (HP:0004386) | 1.84467092 |
| 121 | Amaurosis fugax (HP:0100576) | 1.84315717 |
| 122 | Epistaxis (HP:0000421) | 1.83502801 |
| 123 | Hematochezia (HP:0002573) | 1.83420855 |
| 124 | Episodic fever (HP:0001954) | 1.82439317 |
| 125 | Amyotrophic lateral sclerosis (HP:0007354) | 1.81773087 |
| 126 | Albinism (HP:0001022) | 1.80229660 |
| 127 | Hypochromic anemia (HP:0001931) | 1.79536747 |
| 128 | Spondylolisthesis (HP:0003302) | 1.78877898 |
| 129 | Combined immunodeficiency (HP:0005387) | 1.78791556 |
| 130 | Stomach cancer (HP:0012126) | 1.75415531 |
| 131 | Recurrent sinusitis (HP:0011108) | 1.74578379 |
| 132 | Thrombophlebitis (HP:0004418) | 1.73698197 |
| 133 | Abnormality of the endocardium (HP:0004306) | 1.69726495 |
| 134 | Chronic sinusitis (HP:0011109) | 1.68240379 |
| 135 | IgM deficiency (HP:0002850) | 1.65754876 |
| 136 | Renal cortical cysts (HP:0000803) | 1.64585765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.60536426 |
| 2 | TBK1 | 3.35102949 |
| 3 | IRAK4 | 3.25824112 |
| 4 | TXK | 3.20554174 |
| 5 | RIPK4 | 3.20250113 |
| 6 | IKBKB | 3.14586641 |
| 7 | PBK | 3.07350654 |
| 8 | JAK3 | 3.04250107 |
| 9 | IRAK3 | 2.96469065 |
| 10 | TYK2 | 2.88022463 |
| 11 | IKBKE | 2.86087408 |
| 12 | BLK | 2.85599457 |
| 13 | MAP3K13 | 2.60807721 |
| 14 | BMPR2 | 2.37950613 |
| 15 | MAP4K1 | 2.34921023 |
| 16 | JAK1 | 2.10731677 |
| 17 | CHUK | 2.09945883 |
| 18 | MAP4K2 | 1.90060518 |
| 19 | PIM2 | 1.86098919 |
| 20 | EPHA3 | 1.80633475 |
| 21 | MST4 | 1.80188955 |
| 22 | KIT | 1.68361632 |
| 23 | NEK9 | 1.64344973 |
| 24 | SYK | 1.49616585 |
| 25 | CAMKK2 | 1.42640338 |
| 26 | ZAP70 | 1.36986969 |
| 27 | CSK | 1.27460880 |
| 28 | TEC | 1.22168685 |
| 29 | EPHB1 | 1.20074826 |
| 30 | IRAK1 | 1.19104213 |
| 31 | PIM1 | 1.16839559 |
| 32 | ERN1 | 1.16359217 |
| 33 | BTK | 1.14701665 |
| 34 | HCK | 1.14588797 |
| 35 | RPS6KA4 | 1.13003074 |
| 36 | LCK | 1.11866779 |
| 37 | EIF2AK2 | 1.11419706 |
| 38 | INSRR | 1.09365064 |
| 39 | TRPM7 | 1.06643881 |
| 40 | LYN | 1.04144131 |
| 41 | STK4 | 1.01871982 |
| 42 | JAK2 | 1.01199275 |
| 43 | FGFR4 | 1.00858666 |
| 44 | CSF1R | 1.00576559 |
| 45 | FGFR3 | 1.00224175 |
| 46 | STK10 | 0.99477148 |
| 47 | MUSK | 0.98684614 |
| 48 | TAOK3 | 0.93712245 |
| 49 | ERBB3 | 0.92241378 |
| 50 | ABL2 | 0.89721891 |
| 51 | TRIM28 | 0.85322511 |
| 52 | NLK | 0.82716443 |
| 53 | NME2 | 0.81506226 |
| 54 | MARK3 | 0.78226443 |
| 55 | BMPR1B | 0.75187825 |
| 56 | MST1R | 0.74643529 |
| 57 | BMX | 0.72239952 |
| 58 | PRKCD | 0.71498671 |
| 59 | ITK | 0.71207204 |
| 60 | MATK | 0.69763040 |
| 61 | FRK | 0.69487858 |
| 62 | PAK3 | 0.68438545 |
| 63 | PRKCQ | 0.67531292 |
| 64 | SIK3 | 0.66346881 |
| 65 | PIK3CA | 0.65771501 |
| 66 | STK3 | 0.62351899 |
| 67 | TGFBR2 | 0.61518649 |
| 68 | NUAK1 | 0.60629076 |
| 69 | MOS | 0.60591979 |
| 70 | ABL1 | 0.60322444 |
| 71 | PTK2B | 0.59185988 |
| 72 | LRRK2 | 0.58317192 |
| 73 | SGK2 | 0.58201084 |
| 74 | FGR | 0.56094942 |
| 75 | FER | 0.56051519 |
| 76 | STK24 | 0.54340925 |
| 77 | YES1 | 0.51658465 |
| 78 | MAPKAPK2 | 0.50875231 |
| 79 | ARAF | 0.50678086 |
| 80 | IRAK2 | 0.50652386 |
| 81 | EIF2AK3 | 0.49069352 |
| 82 | TAOK2 | 0.48048895 |
| 83 | MAPK13 | 0.47087486 |
| 84 | EGFR | 0.46460062 |
| 85 | MAP2K3 | 0.46113715 |
| 86 | MAP3K5 | 0.45985862 |
| 87 | OXSR1 | 0.45326028 |
| 88 | EIF2AK1 | 0.44128590 |
| 89 | GRK7 | 0.43743270 |
| 90 | TAOK1 | 0.40366068 |
| 91 | GRK1 | 0.39864046 |
| 92 | MAPKAPK3 | 0.39578127 |
| 93 | GRK5 | 0.39331612 |
| 94 | KSR1 | 0.39287767 |
| 95 | ERBB4 | 0.36626941 |
| 96 | RPS6KA5 | 0.36244876 |
| 97 | MAP3K3 | 0.35251699 |
| 98 | GRK6 | 0.34600964 |
| 99 | MAP3K12 | 0.34432006 |
| 100 | PKN1 | 0.33814934 |
| 101 | WNK3 | 0.33548763 |
| 102 | IGF1R | 0.33348431 |
| 103 | BCR | 0.33336954 |
| 104 | PIK3CG | 0.33186425 |
| 105 | HIPK2 | 0.32558896 |
| 106 | TESK1 | 0.32361949 |
| 107 | MAP3K11 | 0.31488446 |
| 108 | MAP3K1 | 0.31011640 |
| 109 | AKT3 | 0.30979135 |
| 110 | TIE1 | 0.30203894 |
| 111 | SGK3 | 0.24909804 |
| 112 | CLK1 | 0.24308196 |
| 113 | RPS6KA6 | 0.24006767 |
| 114 | FLT3 | 0.22845219 |
| 115 | ACVR1B | 0.22658222 |
| 116 | PRKCE | 0.22376878 |
| 117 | FES | 0.21804655 |
| 118 | ADRBK2 | 0.20297514 |
| 119 | CDK6 | 0.16825400 |
| 120 | MAP3K10 | 0.16414329 |
| 121 | INSR | 0.16168138 |
| 122 | FYN | 0.15620912 |
| 123 | RAF1 | 0.15360461 |
| 124 | RPS6KA1 | 0.15118179 |
| 125 | MAP2K6 | 0.14683952 |
| 126 | MAPK3 | 0.11766899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.85548160 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.47288371 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 3.31732908 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.12347257 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.86453567 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.78806613 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.69392223 |
| 8 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.66813911 |
| 9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.60073252 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.53362131 |
| 11 | Legionellosis_Homo sapiens_hsa05134 | 2.49867202 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.34983082 |
| 13 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.33172883 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29129929 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.27029387 |
| 16 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.25918364 |
| 17 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.19399246 |
| 18 | Malaria_Homo sapiens_hsa05144 | 2.17378160 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 2.08976496 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 2.04220708 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.03178744 |
| 22 | Asthma_Homo sapiens_hsa05310 | 2.01090500 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.87350704 |
| 24 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.77006231 |
| 25 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.76046339 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.71893761 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.71222357 |
| 28 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69040307 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62671336 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.51045743 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.48449198 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46174293 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.42921595 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42398905 |
| 35 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.42147529 |
| 36 | Phagosome_Homo sapiens_hsa04145 | 1.40387464 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37965129 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.26170308 |
| 39 | Shigellosis_Homo sapiens_hsa05131 | 1.18792141 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.18230084 |
| 41 | Lysosome_Homo sapiens_hsa04142 | 1.16385218 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.13386340 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.03170579 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.00166087 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93463611 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.90894034 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88600514 |
| 48 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.86360845 |
| 49 | Amoebiasis_Homo sapiens_hsa05146 | 0.81133695 |
| 50 | Protein export_Homo sapiens_hsa03060 | 0.76765568 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.75946100 |
| 52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.71352944 |
| 53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71002344 |
| 54 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.70064202 |
| 55 | Other glycan degradation_Homo sapiens_hsa00511 | 0.70028975 |
| 56 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68137892 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67974965 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61807811 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60312343 |
| 60 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.60288284 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.57852549 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54772152 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54448910 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50594476 |
| 65 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.48629282 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47799924 |
| 67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46919130 |
| 68 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.45926406 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45079396 |
| 70 | Prion diseases_Homo sapiens_hsa05020 | 0.44896425 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44059661 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.43169757 |
| 73 | Basal transcription factors_Homo sapiens_hsa03022 | 0.43005302 |
| 74 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42487359 |
| 75 | Proteasome_Homo sapiens_hsa03050 | 0.42268929 |
| 76 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42180883 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.40735364 |
| 78 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39525500 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.39159373 |
| 80 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.38532295 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34144807 |
| 82 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32390300 |
| 83 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24793156 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.24360080 |
| 85 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.24115631 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.24099538 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.22616107 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.21390087 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.20402680 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.20220554 |
| 91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.19729768 |
| 92 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.18265226 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17126712 |
| 94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.16054623 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15227583 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.14604623 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.14157363 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.13639143 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.13581392 |
| 100 | Insulin resistance_Homo sapiens_hsa04931 | 0.13460053 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13222353 |
| 102 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.13063979 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.12333878 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.12321662 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.11626721 |
| 106 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.10396161 |
| 107 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.09507367 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.09302968 |
| 109 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.09116144 |
| 110 | RNA degradation_Homo sapiens_hsa03018 | 0.09097074 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.08153883 |
| 112 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.07193952 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.05446784 |
| 114 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.05328813 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.03740533 |
| 116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.02724099 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.01628763 |
| 118 | Mineral absorption_Homo sapiens_hsa04978 | 0.01093470 |

